| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2003 |
| Trial ID | NCT03720496 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19-TriCAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With CD19-TriCART Cell Therapy |
| Year | 2018 |
| Country | China |
| Company sponsor | Timmune Biotech Inc. |
| Other ID(s) | T2018-8 |
| Cohort 1 | |||||||||||||
|
|||||||||||||